Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its innovative and enabling technologies. San Diego, CA-based Arcturus has ...

Chief Executive Officer Joe Payne told investors at the Leerink Partners Global Healthcare Conference that the company has advanced its inhaled messenger RNA cystic fibrosis (CF) program through three ...

Fintel reports that on March 18, 2026, B. Riley Securities initiated coverage of Arcturus Therapeutics Holdings ...

The Arcturus COVID-19 variant has arrived in the United States and is here to stay, according to experts. While it's unclear whether it will drive a summer surge, some doctors are warning that the ...

Arcturus Therapeutics ARCT announced this morning that it has initiated dosing of its Covid-19 vaccine candidate—LUNAR COV-19, (ARCT-021)—in a Phase 1/2 study in collaboration with Duke-NUS Medical ...

The San Diego-based company said it had a loss of $1.03 per share. The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was ...

Women walk past a coronavirus (COVID-19) themed mural on a street in Mumbai, India, March 28, 2023. REUTERS/Francis Mascarenhas A new coronavirus subvariant, XBB. 1.16, has been designated as a ...

Los Angeles County Department of Public Health confirmed three cases of the Arcturus strain with "observational data" suggesting that those infected may be likely to experience pink eye Alexis Jones ...

New Covid strain XBB.1.18, nicknamed arcturus, is quickly spreading across the U.S., but experts are warning that pink eye and high fever, two symptoms of the new variant, are particularly present ...